The FDA's breakthrough therapy designation facilitates accelerated development and regulatory review for therapies showing ...
Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...
Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...
A recent study by Vanderbilt Health researchers has revealed a greater, detrimental role for B lymphocytes (B cells) in the ...
In 2025, Tevogen advanced its proprietary ExacTcell™ platform, expanded its cytotoxic T lymphocyte (CTL) pipeline across ...
In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory ...
Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.
A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening ...